News

News Archive

Accinov, the Innovation Centre of Lyonbiopole, obtains the authorization to open a pharmaceutical site from the French Health authority (ANSM) Accinov, the Innovation Centre of Lyonbiopole, obtains the authorization to open a pharmaceutical site from the French Health authority (ANSM)

Lyonbiopole announces that the French Health authority (ANSM) delivered to Accinov, its Innovation Centre, the authorization to open a pharmaceutical site. This authorization will allow Accinov to support the companies hosted in the Centre for the production of biological drugs for clinical trials in particular with the pharmaceutical responsibility of Accinov

Scripps Research Institute Chemists Modify Antibiotic to Vanquish Resistant Bacteria Scripps Research Institute Chemists Modify Antibiotic to Vanquish Resistant Bacteria

Scientists at The Scripps Research Institute (TSRI) have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria.The new vancomycin analog appears to have not one but two distinct mechanisms of anti-microbial action, against which bacteria probably cannot evolve resistance quickly.“This is the prototype of analogues that once introduced will still be in clinical use a generation or maybe even two generations from now,” said Dale L. Boger, the Richard and Alice Cramer Professor of Chemistry at TSRI.

Western neuroscientists decode vegetative state experiences with Hitchcock film Western neuroscientists decode vegetative state experiences with Hitchcock film

Researchers at Western University have extended their game-changing brain scanning techniques by showing that a short Alfred Hitchcock movie can be used to detect consciousness in vegetative state patients. The study included a Canadian participant who had been entirely unresponsive for 16 years, but is now known to be aware and able to follow the plot of movies.

The Current issue of “The view from here” discusses 3D Cell Culture. The Current issue of “The view from here” discusses 3D Cell Culture.

The topic of this month’s newsletter from Drug Discovery Today is 3D Cell Culture.

KIDS GET APPETITE FOR APP DEVELOPMENT WITH LAUNCH OF NEW STEM COMPETITION KIDS GET APPETITE FOR APP DEVELOPMENT WITH LAUNCH OF NEW STEM COMPETITION

TV presenter Rachel Riley launches ASTELLAS INNOVATION CHALLENGE, a new competition to inspire school students to take up STEM subjects and careers. - Only 37% of school students aged 11 - 16 think they would be likely take up STEM subjects in higher education despite 83% claiming they are interested in these subjects at school

Using Smartphones to Map Parkinson’s and Other Degenerative Diseases Using Smartphones to Map Parkinson’s and Other Degenerative Diseases

Aston Scientist Develops Software to Measure Progression of Degenerative Diseases

Step Towards Breath Test for Lung Cancer Step Towards Breath Test for Lung Cancer

Subtle genetic changes can be detected in the vapour given off by cells engineered to mimic the early stages of lung cancer, according to research published in the British Journal of Cancer today.

Supplementary Protection Certificates (SPCs) are urgently needed to compensate developers of medical devices for lost patent time Supplementary Protection Certificates (SPCs) are urgently needed to compensate developers of medical devices for lost patent time

Medical device manufacturers should be compensated for the lengthy delays involved in obtaining the necessary marketing authorisation to bring new products to market.

Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology

New immunotherapy launched in the US for treatment of adults with advanced melanoma